LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Inicio・Lista de Acciones・Medtronic PLC

Medtronic PLC

Cerrado

SectorSanidad

81.95 4.97

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

78.04

Máximo

82.77

Métricas clave
By Trading Economics
Ingresos	-231M 1.1B
Ventas	57M 9B
P/B Media del Sector	20.665 49.888
BPA	1.36
Rentabilidad por dividendo	3.83
Margen de beneficios	12.675
Empleados	95,000
EBITDA	124M 2.5B

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+27.42% upside

Dividendos
By Dow Jones
Rentabilidad por dividendo Media del Sector	3.83% 2.38%
Fecha Próximo Dividendo	17 jul 2026
Próxima Fecha de Ex Dividendo	26 jun 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-33B 95B
Apertura anterior	76.98
Cierre anterior	81.95

Noticias sobre sentimiento de mercado

By Acuity

37%

63%

105 / 344 Clasificación en Healthcare

Medtronic PLC Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

3 jun 2026, 11:25 UTC

Ganancias

Medtronic Posts Higher 4Q Profit, Sales

20 may 2026, 13:49 UTC

Adquisiciones, fusiones, absorciones

Medtronic to Buy SPR Therapeutics for About $650 Million

10 mar 2026, 11:19 UTC

Adquisiciones, fusiones, absorciones

Medtronic to Buy Scientia Vascular in $550 Million Deal

17 feb 2026, 12:43 UTC

Ganancias

Medtronic 3Q Profit Falls Despite Higher Revenue

3 jun 2026, 11:20 UTC

Ganancias

Medtronic Stock Rises on Earnings. Wall Street Looks Past a Soft Outlook. -- Barrons.com

3 jun 2026, 10:48 UTC

Ganancias

Medtronic Sees FY27 Adj EPS $5.90-Adj EPS $6.00 >MDT

3 jun 2026, 10:47 UTC

Ganancias

Medtronic Sees FY27 Organic Revenue Growth of 6.75%-7.25% >MDT

3 jun 2026, 10:47 UTC

Ganancias

Medtronic Raises Quarterly Dividend to 72c From 71c >MDT

3 jun 2026, 10:45 UTC

Ganancias

Medtronic: Positioned for Continued Momentum Into FY27 >MDT

3 jun 2026, 10:45 UTC

Ganancias

Medtronic 4Q Cardiovascular Portfolio Rev $3.8B >MDT

3 jun 2026, 10:45 UTC

Ganancias

Medtronic 4Q Net $1.24B >MDT

3 jun 2026, 10:45 UTC

Ganancias

Medtronic 4Q Organic Revenue Up 6.6% >MDT

3 jun 2026, 10:45 UTC

Ganancias

Medtronic 4Q Neuroscience Portfolio Rev $2.75B >MDT

3 jun 2026, 10:45 UTC

Ganancias

Medtronic 4Q Medical Surgical Portfolio Rev $2.39B >MDT

3 jun 2026, 10:45 UTC

Ganancias

Medtronic 4Q EPS 96c >MDT

3 jun 2026, 10:45 UTC

Ganancias

Medtronic 4Q Sales $9.81B >MDT

3 jun 2026, 10:45 UTC

Ganancias

Medtronic 4Q Adj EPS $1.55 >MDT

20 may 2026, 13:15 UTC

Adquisiciones, fusiones, absorciones

Medtronic Announces Intent To Acquire SPR Therapeutics, Inc., Expanding Care Options For People Living With Chronic Pain >MDT

20 may 2026, 13:15 UTC

Adquisiciones, fusiones, absorciones

Medtronic to Buy SPR Therapeutics for About $650 Million in Cash >MDT

22 abr 2026, 11:27 UTC

Ganancias

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

20 abr 2026, 11:50 UTC

Adquisiciones, fusiones, absorciones

Medtronic Completes Acquisition Of CathWorks, Expanding Its Leadership In Transforming Care For Patients With Cardiovascular Disease >MDT

24 mar 2026, 20:59 UTC

Ganancias

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

10 mar 2026, 10:46 UTC

Adquisiciones, fusiones, absorciones

Medtronic: Scientia Deal Complements Neurovascular Portfolio >MDT

10 mar 2026, 10:46 UTC

Adquisiciones, fusiones, absorciones

Medtronic: Scientia Deal Includes Potential Undisclosed Earn-Out, Milestone Payments >MDT

10 mar 2026, 10:45 UTC

Adquisiciones, fusiones, absorciones

Medtronic: Scientia Vascular Acquisition Valued at $550 Million >MDT

10 mar 2026, 10:45 UTC

Adquisiciones, fusiones, absorciones

Medtronic to Acquire Scientia Vascular >MDT

17 feb 2026, 21:21 UTC

Ganancias

These Stocks Are Today's Movers: Paramount, Masimo, Medtronic, Kyndryl, eToro, Genuine Parts, Southwest, and More -- Barrons.com

17 feb 2026, 18:11 UTC

Ganancias

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 feb 2026, 14:48 UTC

Ganancias

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 feb 2026, 13:00 UTC

Ganancias

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

Comparación entre iguales

Cambio de precio

Medtronic PLC previsión

Precio Objetivo

By TipRanks

27.42% repunte

Estimación a 12 Meses

Media 99.32 USD 27.42%

Máximo 120 USD

Mínimo 80 USD

De acuerdo con 20 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Medtronic PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

20 ratings

Comprar

Mantener

Vender

De acuerdo con 20 analistas que ofrecen calificaciones bursátiles a para Medtronic PLC Dist en los últimos 3 meses.

Sentimiento

By Acuity

105 / 344 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.